Rein Therapeutics Announces Preliminary Blinded Phase 2 RENEW Data Showing Encouraging Lung Function Trends in Patients with Idiopathic Pulmonary Fibrosis and Reports Third Quarter 2026 Financial Results
GlobeNewswire · 财报与经营业绩 · November 16, 2026 at 7:30 AM ET
Read the full report at the original publisher.